biotech
NHS no longer able to deliver on standards, warn bosses
January 11, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The struggles of the NHS this winter are no secret, especially after being front and centre of the first Prime …
New project examining FDA-approved drugs for Alzheimer’s, worries over research remains
January 10, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …
Slow-release, once-weekly pill for HIV developed
January 10, 2018Research and Development HIV, Lyndra, biotech, drugs, pharma, pharmaceutical
Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not …
Swallowable capsules could revolutionise bowel disorder treatment
January 9, 2018Research and Development biotech, drugs, pharma, pharmaceutical
Researchers from RMIT University in Australia were tasked with developing a more effective breath test for determining what was happening …
Six-strong collaboration to sequence 500,000 exomes
January 9, 2018Manufacturing and Production, Research and Development UK Biobank, biotech, drugs, pharma, pharmaceutical
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of …
Hunt resists move from health secretary position, receives expanded role
January 9, 2018Manufacturing and Production, Medical Communications Jeremy Hunt, NHS, Theresa May, biotech, drugs, pharma, pharmaceutical
As part of Theresa May’s well-publicised cabinet reshuffle, many were expecting Jeremy Hunt to move from his position as Secretary …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
Sanofi and Alynylam rejig sees global rights switch-up
January 8, 2018Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
Celgene in $7bn shot on Impact
January 8, 2018Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical
Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
Pfizer exits neuroscience R&D space
January 8, 2018Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …
Novartis Pharma Ex-CEO takes three roles in two days
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical
Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Takeda agrees $630m takeover of TiGenix
January 5, 2018Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical
Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …
Common virus able to target brain cancer
January 4, 2018Medical Communications, Research and Development biotech, brain cancer, drugs, pharma, pharmaceutical
Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …
Pfizer makes $830m drug discovery pact with Arvinas
January 4, 2018Research and Development, Sales and Marketing Arvinas, Pfizer, biotech, drugs, pharma, pharmaceutical
Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …
Allergan to axe over 1,000 positions in cost cutting measures
January 4, 2018Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, …
Latest content
